Announce Date | 02/19/2025 |
EPS Normalized Actual | $1.63 (Beat by $0.09) |
EPS GAAP Actual | $1.63 (Beat by $0.09) |
Revenue Actual | $2.42317B |
Revenue Surprise | Beat by $2423.17M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Nov 2028 | 11.74 | 14.81 | 11.00804 | 12.94451 | 2 |
Oct 2028 | 11.74 | 14.81 | 10.94971 | 13.60512 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Feb 2025) | 0.79 | 0.79 | 2.42317B | -3.69% | 2423.17M |
FQ4 2024 (Nov 2024) | 0.96 | 0.96 | 2.44321B | -11.18% | 2443.21M |
FQ3 2024 (Aug 2024) | 0.79 | 0.79 | 2.31221B | -33.05% | 2312.21M |
FQ2 2024 (May 2024) | 0.61 | 0.61 | 2.15904B | -51.13% | 2159.04M |
FQ1 2024 (Feb 2024) | 0.93 | 0.93 | 2.5127B | -29.33% | 2512.7M |
FQ4 2023 (Oct 2023) | 0.99 | 0.99 | 2.71648B | -19.56% | 2716.48M |
FQ3 2023 (Jul 2023) | 1.75 | 1.75 | 3.0765B | -1.08% | 3076.5M |
FQ2 2023 (Apr 2023) | 1.94 | 1.94 | 3.26293B | 100% | 3262.93M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 2.92355 | -- | 2.79591 | 3.08668 | 10 |
FQ3 2027 (Jul 2027) | 2.76486 | -- | 2.64415 | 2.91914 | 10 |
FQ2 2027 (Apr 2027) | 2.5969 | -- | 2.48352 | 2.74181 | 10 |
FQ1 2027 (Feb 2027) | 2.50071 | -- | 2.39153 | 2.64025 | 10 |
FQ4 2026 (Oct 2026) | 2.45438 | -- | 2.34722 | 2.59133 | 10 |
FQ3 2026 (Aug 2026) | 2.70267 | -- | 2.56324 | 2.82444 | 15 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 3.44B | -- | 3.33B | 3.59B | 11 |
FQ3 2027 (Jul 2027) | 3.32B | -- | 3.21B | 3.46B | 19 |
FQ2 2027 (Apr 2027) | 3.18B | -- | 3.08B | 3.32B | 11 |
FQ1 2027 (Feb 2027) | 3.14B | -- | 3.03B | 3.27B | 13 |
FQ4 2026 (Oct 2026) | 3.07B | -- | 2.97B | 3.2B | 21 |
FQ3 2026 (Aug 2026) | 3.22B | -- | 3.1B | 3.34B | 16 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Feb 2025) | 0.79 | 0.79 | 100% | |
FQ4 2024 (Nov 2024) | 0.96 | 0.96 | 100% | |
FQ3 2024 (Aug 2024) | 0.79 | 0.79 | 100% | |
FQ2 2024 (May 2024) | 0.61 | 0.61 | 100% | |
FQ1 2024 (Feb 2024) | 0.93 | 0.93 | 100% | |
FQ4 2023 (Oct 2023) | 0.99 | 0.99 | 100% | |
FQ3 2023 (Jul 2023) | 1.75 | 1.75 | 100% | |
FQ2 2023 (Apr 2023) | 1.94 | 1.94 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Feb 2025) | $0B | $2.42B | $2423.17M | 100% |
FQ4 2024 (Nov 2024) | $0B | $2.44B | $2443.21M | 100% |
FQ3 2024 (Aug 2024) | $0B | $2.31B | $2312.21M | 100% |
FQ2 2024 (May 2024) | $0B | $2.16B | $2159.04M | 100% |
FQ1 2024 (Feb 2024) | $0B | $2.51B | $2512.7M | 100% |
FQ4 2023 (Oct 2023) | $0B | $2.72B | $2716.48M | 100% |
FQ3 2023 (Jul 2023) | $0B | $3.08B | $3076.5M | 100% |
FQ2 2023 (Apr 2023) | $0B | $3.26B | $3262.93M | 100% |